IntraGel Therapeutics
PrivateLast Round
Seed
Aug 3, 2023
Total Funding Raised
$450,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IntraGel Therapeutics is a biotechnology company that develops a proprietary gel-based drug delivery platform, SRGel, for the localized and sustained release of anti-cancer medications in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IntraGel Therapeutics Comparables
Compare IntraGel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gordian Pharma Ltd. | 79% | |
| Johnson & Johnson | 70% | |
| Everfront Biotech Inc. | 66% |
IntraGel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 3, 2023 | ||||
| Pre Seed | May 1, 2023 | ||||
| Accelerator | Jul 21, 2022 | ||||
| Seed | Aug 1, 2021 |
IntraGel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Pre Seed |
| Next Generation Technology (NGT3VC) | Seed |
| MassChallenge Israel | Accelerator |
| NGT HealthCare II | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 481% MoM, reaching 1.4K.
- May 1, 2023
$450K raised from NGT HealthCare II and Israel Innovation Authority.
Recent news
Latest coverage and updates
- receives_financingAug 20, 2026
Intragel Therapeutics Ltd. received financing of $7M in financing round on Aug 20th '26.
- partners_withAug 20, 2026
Intragel Therapeutics Ltd. partnered with UroGen Pharma, Inc. on Aug 20th '26.
IntraGel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IntraGel Therapeutics's valuation, stock price, and market status.
Is IntraGel Therapeutics a public or private company?
IntraGel Therapeutics is a private company.
What is the current stock price of IntraGel Therapeutics?
IntraGel Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is IntraGel Therapeutics worth (valuation)?
Valuation information for IntraGel Therapeutics is not publicly available.
Can I buy IntraGel Therapeutics stock?
IntraGel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IntraGel Therapeutics's last funding round?
IntraGel Therapeutics's most recent funding round was Seed on August 3, 2023.
Who are the main investors in IntraGel Therapeutics?
Key investors in IntraGel Therapeutics include Next Generation Technology (NGT3VC).
Will IntraGel Therapeutics IPO soon?
No public IPO plans have been announced for IntraGel Therapeutics.
How can I track IntraGel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IntraGel Therapeutics's secondary market activity and sign up for updates.